<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00943007</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 08-2-055</org_study_id>
    <nct_id>NCT00943007</nct_id>
  </id_info>
  <brief_title>Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors</brief_title>
  <acronym>RACING</acronym>
  <official_title>Randomized Assessment of Conventional Neuronavigation Versus Intraoperative MRI for the Neurosurgical Treatment of Glioblastomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of a specific subtype of highly malignant brain tumor (called &quot;glioblastoma&quot; or
      &quot;glioblastoma multiforme&quot;) consists of neurosurgical resection, followed by radiotherapy and
      mostly chemotherapy as well. Increased extent of tumor resection is associated with prolonged
      survival. The standard treatment uses conventional neuronavigation systems to increase extent
      of tumor resection. However, the quality of this form of neuronavigation decreases throughout
      surgery because of &quot;brain shift&quot;. This is caused by edema, loss of cerebrospinal fluid and
      tumor resection. A new form of neuronavigation uses intraoperative MRI to compensate for
      brain shift, and to check for the presence of residual tumor that can be removed.

      This study aims to compare the extent of glioblastoma resection between the standard
      treatment and intraoperative MRI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Residual tumor volume</measure>
    <time_frame>&lt;72h after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications, Clinical Performance, and Quality of Life</measure>
    <time_frame>3 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>2 years after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Glioblastoma Multiforme</condition>
  <arm_group>
    <arm_group_label>Conventional Neuronavigation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard form of neuronavigation: based on preoperative MRI without intraoperative correction for brain shift</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraoperative MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard neuronavigation plus intraoperative MRI to correct for brain shift</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stealth Station</intervention_name>
    <description>Neuronavigation based on preoperative MRI</description>
    <arm_group_label>Conventional Neuronavigation</arm_group_label>
    <other_name>cNN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PoleStar N20</intervention_name>
    <description>Intraoperative MRI guided surgery</description>
    <arm_group_label>Intraoperative MRI</arm_group_label>
    <other_name>iMRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  supratentorial brain tumor, on contrast enhanced dMRI suspected to be GBM

          -  indication for gross total resection (GTR) of the tumor

          -  age ≥18 years

          -  WHO Performance Scale ≤ 2

          -  ASA class ≤ 3

          -  adequate knowledge of the Dutch or French language

          -  informed consent

        Exclusion Criteria:

          -  recurrent brain tumor

          -  multiple brain tumor localizations

          -  earlier skull radiotherapy

          -  earlier chemotherapy for GBM

          -  Chronic Kidney Disease or other renal function disorder

          -  known MR-contrast allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henk van Santbrink, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Martin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Liege</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Koo van Overbeeke, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liege</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2009</study_first_submitted>
  <study_first_submitted_qc>July 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2009</study_first_posted>
  <last_update_submitted>April 9, 2015</last_update_submitted>
  <last_update_submitted_qc>April 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

